Navigation Links
Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line

FREEPORT, N.Y., Feb. 4 /PRNewswire/ -- AGI Dermatics, the bio-pharmaceutical laboratory that pioneered DNA research for skincare will introduce four innovative products to the Remergent line: Advanced Retinol Therapy (1% retinol), Progressive Retinol Complex (0.4% retinol), Clarifying Concentrate2 and Complete Cleanser.

"The new products include our first retinol-based formulas and reinforce our commitment to harnessing the power of the industry's most effective anti-aging ingredients," said Daniel Yarosh, Ph.D., President of AGI Dermatics. "Although best known for our DNA repair enzyme technology, the Remergent brand is, at its heart, a superior anti-aging line with a full-range of products that complement each other to prevent, protect, treat and repair photo damage."

Remergent is the brand recommended by top dermatologists across the country to help repair the consequences of sun damage and reverse the signs of photo aged skin. Available from medical professionals, Remergent is the first product line to use sophisticated formulas to target DNA repair, barrier re-building, pigmentary issues, discolorations from the sun and other skin concerns. The introduction of the four new products boosts the scope and the efficacy of the current treatment products.

-- Advanced Retinol Therapy -- is an intensive skin perfecting treatment

formulated with 1% retinol, the highest non-prescription concentration

available, to firm the collagen network, accelerate cell turnover and

minimize the appearance of fine lines, wrinkles, age spots and uneven

skin tone without irritation.

-- Progressive Retinol Complex -- is a skin perfecting treatment

formulated with 0.4% retinol for use on more sensitive skin or as a

first line treatment to prepare skin for the more intensive benefits of

Advanced Retinol Therapy.

-- Clarifying Concentrate2 -- safely and gently diminishes the appearance

of localized discolorations on the face, hands, arms and shoulders.

-- Complete Cleanser -- provides pH-correction to condition and prepare

the skin for optimum formula delivery and treatment results.

The new Remergent retinol products will be introduced in early 2008. Currently, Remergent products are available from dermatologists and plastic surgeons. For more information, please visit or call 800-590-4244.

About AGI Dermatics

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals.

SOURCE AGI Dermatics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
4. Medarex Announces Completion of Sale of Shares in Genmab A/S
5. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
6. Rigel Announces Pricing of Public Offering of Common Stock
7. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
8. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
9. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
10. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
11. GeoPharma Announces Third Quarter Conference Call
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):